Skip to content

Arcus Biosciences RCUS Asset turnover

Asset turnover at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
0.5×0.0×
Merck & Co. logo
Merck & Co.MRK
0.5×0.0×
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
0.4×0.0×
AbbVie logo
AbbVieABBV
0.5×+0.1×
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
0.0×
Incyte logo
IncyteINCY
0.8×+0.1×

Other financials

Income statement

See full
Revenue$17.0M-39.3%
Operating income-$134.0M-9.8%
Net income-$128.0M-14.3%
EPS (diluted)-$1.02+10.5%

Balance sheet

See full
Cash & equivalents$201.0M+4.7%
Total debt$113.0M+88.3%
Total equity$524.0M-1.3%
Total assets$997.0M-13.8%

Cash flow

See full
Operating cash flow-$138.0M-4.5%
CapEx--100%
Free cash flow-$138.0M-3.8%

Valuation

See full
Market cap$3.54B+226%
Enterprise value$3.46B+275%
P/S15×+7.3×

Profitability

See full
Operating margin-168.6%-52.7pp
Net margin-156.4%-47.5pp
FCF margin-207.2%

Returns & leverage

See full
Return on equity-70%+8.4pp
Debt / equity0.2×+0.1×
Current ratio-1.3×

Where this comes from

Calculated from Arcus Biosciences’s reported figures.

Based on trailing twelve months.

The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcus Biosciences's asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arcus Biosciences's asset turnover?
Arcus Biosciences (RCUS) reported asset turnover of 0.2× in Q1 2026.
How has Arcus Biosciences's asset turnover changed year-over-year?
Arcus Biosciences's asset turnover increased by 90.4% year-over-year, from 0.1× to 0.2×.
What is the long-term trend for Arcus Biosciences's asset turnover?
Over 5 years (2020 to 2025), Arcus Biosciences's asset turnover has grown at a 6.2% compound annual growth rate (CAGR), from 0.2× to 0.2×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.